Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.22.2.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Aug. 31, 2022
Aug. 31, 2021
Consolidated Statements of Operations    
Revenue [1]   $ 41
Cost of goods sold [1]   1
Gross margin [1]   40
Operating expenses:    
General and administrative $ 6,333 7,617 [1]
Research and development 576 12,020 [1]
Amortization and depreciation 99 276 [1]
Inventory charge 2,704 1,764 [1]
Total operating expenses 9,712 21,677 [1]
Operating loss (9,712) (21,637) [1]
Interest and other expense:    
Interest on convertible notes (1,146) (1,686) [1]
Amortization of discount on convertible notes (576) (952) [1]
Amortization of debt issuance costs (16) (28) [1]
Loss on induced conversion [1]   (18,530)
Finance charges (940) (35) [1]
Inducement interest expense [1]   (528)
Legal settlement [1]   (1,941)
Loss on derivatives (8,601)  
Total interest and other expense (11,279) (23,700) [1]
Loss before income taxes (20,991) (45,337) [1]
Income tax benefit 0 0 [1]
Net loss $ (20,991) $ (45,337) [1]
Weighted average common shares outstanding, Basic 787,856 632,597 [1]
Weighted average common shares outstanding, Diluted 787,856 632,597
Loss per share, Basic $ (0.03) $ (0.07) [1]
Loss per share, Diluted $ (0.03) $ (0.07)
[1] See Note 2, Summary of Significant Accounting Policies.